Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
16 angezeigte Treffer · Seite 1, keine Gesamtzahl für „lenacapavir“
Suchtreffer
Begriffe & Kennungen
Sunlenca · 4.5 · 8 b This study was conducted using lenacapavir 300 mg single dose administered orally. c Evaluated as a strong
Eintrag öffnenSunlenca · 4.5 · Co-administation of ritonavir may increase lenacapavir plasma concentrations. Tenofovir alafenamided,i,j (25 m
Eintrag öffnenSunlenca · 4.5 · Co-administation of ritonavir may increase lenacapavir plasma concentrations. Tenofovir alafenamided,i,j (25 m
Eintrag öffnenSunlenca · 4.5 · Effect of lenacapavir on the pharmacokinetics of other medicinal products
Eintrag öffnenSunlenca · 4.5 · Effect of lenacapavir on the pharmacokinetics of other medicinal products
Eintrag öffnenSunlenca · 4.5 · Effect of other medicinal products on the pharmacokinetics of lenacapavir
Eintrag öffnenSunlenca · 4.5 · Effect of other medicinal products on the pharmacokinetics of lenacapavir
Eintrag öffnenSunlenca · 4.5 · Lenacapavir is a moderate inhibitor of CYP3A and a P-gp inhibitor. Caution is advised if Sunlenca is co-admini
Eintrag öffnenSunlenca · 4.5 · Lenacapavir is a moderate inhibitor of CYP3A and a P-gp inhibitor. Caution is advised if Sunlenca is co-admini
Eintrag öffnenSunlenca · 4.5 · Lenacapavir is a substrate of CYP3A, P-gp and UGT1A1. Strong inducers of CYP3A, P-gp, and UGT1A1, such as rifa
Eintrag öffnenSunlenca · 4.5 · Lenacapavir is a substrate of CYP3A, P-gp and UGT1A1. Strong inducers of CYP3A, P-gp, and UGT1A1, such as rifa
Eintrag öffnenSunlenca · 4.5 · Plasma concentration of triazolam may be increased when co-administered with lenacapavir. ANTICOAGULANTS Direc
Eintrag öffnenSunlenca · 4.5 · Plasma concentration of triazolam may be increased when co-administered with lenacapavir. ANTICOAGULANTS Direc
Eintrag öffnenlenacapavir
Eintrag öffnenlenacapavir sodium
Eintrag öffnenlenacapavir sodium
Eintrag öffnen